Get your free personalized podcast brief
We scan new podcasts and send you the top 5 insights daily.
Rather than backing early-stage startups where failure is common, Dan Fleischmann deploys syndicate checks of $3 million to $6 million into businesses generating between $5 million and $20 million in revenue. Across 18 syndicate investments, only 3 failed. Backing businesses that already have traction dramatically reduces syndicate risk and prevents reputational damage with investors.
Related Insights
An analysis of 547 Series B deals reveals two-thirds return less than 2x. This data demonstrates that a "spray and pray" strategy fails at this stage. The cost of misses is too high, and being even slightly worse than average in your picks will result in a failed fund. Discipline and picking are paramount.
The deadliest startup phase is the 'sapling' stage: post-launch but pre-repeatability (under ~$5M ARR). Unlike the seed stage (planting) or scale stage (tree), this phase requires bespoke, non-scalable help to navigate the maze of finding the right customer and problem before the company withers.
Experience shows that companies below a $50 million revenue threshold typically lack the necessary systems, processes, and people to support a significant transformation. This creates a bright-line rule for Speyside: go small for bolt-ons, but not for platform companies that require a turnaround, as the risk-weighted returns are unfavorable.
Before accepting friends-and-family or angel investment, founders should first validate their business by securing initial MRR. This early traction provides tangible evidence that you're on the right track, helps justify a fair valuation, and builds confidence for both the founder and the investors.
The bar for pre-seed funding has risen dramatically. With an abundance of startups already generating revenue (e.g., $1M ARR), VCs are choosing these de-risked opportunities over pure idea-stage companies. This "flight to quality" has bifurcated the market, making it extremely difficult for pre-revenue founders to raise.
Early-stage angel investing is often a high-risk bet on an idea. In contrast, York IE's institutional approach targets companies with initial traction ($500K+ ARR) that are ready for operational support. The value-add shifts from just capital to providing an infrastructure for predictable growth.
TeamShares initially focused on buying very small companies. They discovered this segment produced a "wide variance of outcomes," similar to a venture capital portfolio. To achieve their goal of predictable compounding, they shifted their focus to slightly larger, more stable businesses with $500k to $5M in EBITDA.
A large, outbound sourcing team is only logical for funds targeting sub-$10M revenue businesses. Companies above that threshold are almost always represented by investment bankers, making a banker-centric deal flow strategy more efficient for larger private equity funds.
Contrary to the popular search fund model of targeting $1M+ EBITDA businesses, a less risky path is to start with smaller companies ($100k-$250k earnings). This lowers complexity, reduces the potential for catastrophic failure, and provides invaluable hands-on experience for first-time acquirers.
Founders often believe fundraising failure stems from a lack of connections. However, for early-stage consumer brands with low sales figures, the real barrier is insufficient traction data. VCs need proof of scalability, like a major distribution deal, before they will invest, regardless of the introduction.
